Search Results
Dr. Kris on the Future of Immunotherapy and Targeted Therapy in Lung Cancer
Dr. Kris on the Future of Lung Cancer
Dr. Mark Kris on Immunotherapy and Frontline Options for Patients With NSCLC
Dr. Kris on Combination Chemotherapy Approaches in NSCLC
Dr. Kris on Personalizing Therapy in Lung Cancer
Dr. Kris Discusses Role of Antiangiogenesis in Lung Cancer
Standard of Care Therapy in Lung Cancer Be Open to New Ideas
Novel Lung Cancer Therapy: Future Improvements and Challenges
Mark Kris on New Therapies for Lung Cancer
Dr. Kris on Search for Biomarkers in Advanced Squamous NSCLC
Dr. Mark Kris on the Combination of Molecularly Targeted Therapies
Mark Kris, MD: Antiangiogenic Therapy in NSCLC
